Multiple forms of estrogen receptor-α in cerebral blood vessels: Regulation by estrogen

American Journal of Physiology - Endocrinology and Metabolism

Volumn 284, Issue 1 47-1, 2003, Pages

  Stirone, Chris ^a   Duckles, Sue P ^a   Krause, Diana N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

17 estradiol; 26S proteasome; Cerebral circulation; Estrogen receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; LACTACYSTIN; PROTEASOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CIRCULATION; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY;

EID: 0037225649     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00165.2002     Document Type: Article

References (41)

1. Alarid ET, Bakopoulos N, and Solodin N. Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation. Mol Endocrinol 13: 1522-1534, 1999.
2. Arribas SM, Vila E, and McGrath JC. Impairment of vasodilator function in basilar arteries from aged rats. Stroke 28: 1812-1820, 1997.
3. Asaithambi A, Mukherjee S, and Thakur MK. Expression of 112-kDa estrogen receptor in mouse brain cortex and its auto-regulation with age. Biochem Biophys Res Commun 231: 683-685, 1997.
4. Barraille P, Chinestra P, Bayard F, and Faye JC. Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERα. Biochem Biophys Res Commun 257: 84-89, 1999.
5. Drummond AE, Baillie AJ, and Findlay JK. Ovarian estrogen receptor alpha and beta mRNA expression: Impact of development and estrogen. Mol Cell Endocrinol 149: 153-161, 1999.
6. Edvinsson L and Krause DN. Cerebral Blood Flow and Metabolism. Philadelphia, PA: Lippincott, Williams and Wilkins, 2002.
7. Figtree GA, Webb CM, and Collins P. Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J Pharmacol Exp Ther 295: 519-523, 2000.
8. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, and Gannon F. Identification of a new isoform of the human estrogen receptor-alpha that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J 19: 4688-4700, 2000.
9. Geary GG, Krause DN, and Duckles SP. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol Heart Circ Physiol 275: H292-H300, 1998.
10. Geary GG, Krause DN, and Duckles SP. Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms. Am J Physiol Heart Circ Physiol 279: H511-H519, 2000.
11. Geary GG, McNeill AM, Ospina JA, Krause DN, and Duckles SP. Selected contribution: Cerebrovascular NOS and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha. J Appl Physiol 91: 2391-2399, 2001.
12. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, and Chambon P. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature 320: 134-139, 1986.
13. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, and Shine J. Sequence and espression of human estrogen receptor complementary DNA. Science 231: 1150-1154, 1986.
14. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, and Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 87: 677-682, 2000.
15. Horigome T, Ogata F, Golding TS, and Korach KS. Estradiol-stimulated proteolytic cleavage of the estrogen receptor in mouse uterus. Endocrinology 123: 2540-2548, 1988.
16. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, and Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med 3: 545-548, 1997.
17. Itoh M, Takaoka M, Shibata A, Ohkita M, and Matsamura Y. Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 298: 501-507, 2001.
18. Joel PB, Traish AM, and Lannigan DA. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 273: 13317-13323, 1998.
19. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, and Mendelsohn ME. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci USA 96: 15133-15136, 1999.
20. Kemppainen JA, Lane MV, Sar M, and Wilson EM. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. J Biol Chem 267: 968-974, 1992.
21. Khissiin AE and Leclerq G. Implication of proteasome in estrogen receptor degradation. FEBS Lett 448: 160-166, 1999.
22. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, and Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem Biophys Res Commun 263: 257-262, 1999.
23. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, and Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996.
24. Lange CA, Shen T, and Horwitz KB. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97: 1032-1037, 2000.
25. Maaroufi Y, Lacroix M, Lespagnard L, Journe F, Larsimont D, and Leclercq G. Estrogen receptor of primary breast cancers: Evidence for intracellular proteolysis. Breast Cancer Res 2:444-454, 2000.
26. McNeill AM, Kim N, Duckles SP, and Krause DN. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30: 2186-2190, 1999.
27. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, and Krause DN. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: Effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33: 1685-1691, 2002.
28. Monje P and Boland R. Characterization of membrane estrogen binding proteins from rabbit uterus. Mol Cell Endocrinol 147:75-84, 1999.
29. Morey AK, Pedram A, Razandi M, Prins BA, Hu RM, Biesiada E, and Levin ER. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138: 3330-3339, 1997.
30. Nawaz Z, Lonard DM, Dennis AP, Smith CL, and O'Malley BW. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96: 1858-1862, 1999.
31. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, and Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 81: 1535-1565, 2001.
32. Ospina JA, Krause DN, and Duckles SP. 17β-Estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33: 600-605, 2002.
33. Pasqualini C, Guivarc'h D, Barnier JV, Guibert B, Vincent JD, and Vernier P. Differential subcellular distribution and transcriptional activity of ΣE3, ΣE4, ΣE3-4 isoforms of the rat estrogen receptor-α. Mol Endocrinol 15: 894-908, 2001.
34. Pelligrino DA and Galea E. Estrogen and cerebrovascular physiology and pathophysiology. Jpn J Pharmacol 86: 137-158, 2001.
35. Pendaries C, Darblade B, Krust A, Chambon P, Korach KS, Bayard F, and Arnal JF. The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci USA 99: 2205-2210, 2002.
36. Powell CE, Soto AM, and Sonnenschein C. Identification and characterization of membrane estrogen receptor from MCF-7 estrogen-target cells. J Ster Biochem Mol Biol 77: 97-108, 2001.
37. Russell KS, Haynes MP, Sinha D, Clerisme E, and Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97: 5930-5935, 2000.
38. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, and Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. J Biol Chem 275: 5026-5030, 2000.
39. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, and Bilfinger TV. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101: 1594-1597, 1999.
40. Wijayaratne AL and McDonnell DP. The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276: 35684-35692, 2001.
41. Zhang L, Fishman MC, and Huang PL. Estrogen mediates the protective effects of pregnancy and chorionic gonadotropin in a mouse model of vascular injury. Arterioscler Thromb Vasc Biol 19:2059-2065, 1999.